{"id":"W4387966665","doi":"10.1093/eurheartj/ehad668","title":"Icosapent ethyl for hypertriglyceridaemia and atherosclerosis: greater RESPECT for increased therapeutic use","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Pharmaceuticals; National Heart, Lung, and Blood Institute; St. Jude Medical; HLS Therapeutics; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Pfizer; Moderna; Belvoir Media Group; MyoKardia; Novo Nordisk; Medicines Company; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Assistance publique-Hôpitaux de Paris; National Institutes of Health; Regeneron Pharmaceuticals; Duke Clinical Research Institute; Eisai; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; CSL Behring; Amgen; Sanofi; American Heart Association","keywords":"Medicine; Eicosapentaenoic acid; Intensive care medicine; Fatty acid; Biochemistry; Polyunsaturated fatty acid","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004677441,0.0004856988,0.001458579,0.0007131562,0.0002728855,0.002603912,0.0005063501,0.001932661,0.01980187],"category_scores_gemma":[0.01305934,0.000175567,0.00141588,0.0008221572,0.0006616149,0.001679998,0.0007974048,0.004109426,0.001609097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006980501,"about_ca_system_score_gemma":0.001242722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006073377,"about_ca_topic_score_gemma":0.001601308,"domain_scores_codex":[0.9979264,0.001165945,0.0002719506,0.0001919833,0.0003385968,0.0001051404],"domain_scores_gemma":[0.9908138,0.005797982,0.001635873,0.0002801025,0.0009290034,0.0005432238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.009996879,0.0001359934,0.002637131,0.01026327,0.0009577314,0.0003020334,0.00009380349,0.0003580276,0.001724436,0.007789826,0.04201084,0.9237301],"study_design_scores_gemma":[0.01259091,0.01047034,0.05023351,0.04009634,0.008203955,0.003535851,0.0009818118,0.002048405,0.004289754,0.03610558,0.8310218,0.0004217198],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.02001087,0.7791658,0.003491104,0.1613765,0.009328955,0.000170262,0.0007907352,0.0001953472,0.02547048],"genre_scores_gemma":[0.2482705,0.6114036,0.01527735,0.08609532,0.02983066,0.000285273,0.0008490777,0.0001833916,0.007804813],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01980187,"threshold_uncertainty_score":0.06624389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1780108553326505,"score_gpt":0.3677389145088181,"score_spread":0.1897280591761676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}